J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chisholm, S. A.
Right arrow Articles by Owen, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chisholm, S. A.
Right arrow Articles by Owen, R. J.
Agricola
Right arrow Articles by Chisholm, S. A.
Right arrow Articles by Owen, R. J.
J Med Microbiol 53 (2004), 135-140; DOI: 10.1099/jmm.0.05342-0
© 2004 Society for General Microbiology
ISSN 0022-2615

Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori

Stephanie A. Chisholm and Robert J. Owen

Helicobacter Reference Unit, Laboratory of Enteric Pathogens, Specialist and Reference Microbiology Division, Health Protection Agency, 61 Colindale Avenue, Colindale, London NW9 5HT, UK

Correspondence Stephanie A. Chisholm stephanie.chisholm{at}hpa.org.uk

Received June 6, 2003
Accepted November 5, 2003

Mutations in the NAD(P)H flavin oxidoreductase gene (frxA) are thought to contribute to the development of metronidazole resistance in Helicobacter pylori. To test this further, 44 frxA sequences in 18 patient isolate sets of H. pylori were examined including a unique collection comprising separated Mtz-sensitive (MtzS) and Mtz-resistant (MtzR) subpopulations pre-treatment and matched MtzR strains post-treatment. Sequences of frxA contained frameshift mutations that led to premature protein truncation in at least one strain from most (17/18) patient sets. These mutations were present in all strains, irrespective of Mtz resistotype in 13/18 patients. Frameshift due to a single adenine deletion at nucleotide 53 was the most common mutation and was present in isolates from 11/18 patients. A novel real-time (LightCycler) PCR-based probe hybridization melting-point assay applied to a further 119 isolates confirmed that the frameshift-53 mutation occurred frequently, in 20 % of isolates, and could be present in MtzS as well as MtzR strains (42 % vs 58 %). This study demonstrates that frameshift mutations occur in MtzS strains as well as in MtzR strains, and are thus unlikely to cause Mtz resistance.


Abbreviations: MtzR, Mtz-resistant; MtzS, Mtz-sensitive.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. M. Moore and N. R. Salama
Mutational Analysis of Metronidazole Resistance in Helicobacter pylori
Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1236 - 1237.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
M. M Gerrits, E.-J. van der Wouden, D. A Bax, A. A van Zwet, A. H. van Vliet, A. de Jong, J. G Kusters, J. C Thijs, and E. J Kuipers
Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori
J. Med. Microbiol., November 1, 2004; 53(11): 1123 - 1128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2004 Society for General Microbiology.